June 2026 in “Bulletin of Mathematical Biology” This study reported that in male subjects with androgenetic alopecia, there is greater uncertainty in hair growth duration, with regulatory factors in the dermal papilla significantly affecting outcomes.
December 2023 in “Expert Opinion on Drug Safety” This abstract raises concerns about the safety of finasteride, a medication often used for treating hair loss and prostate issues, due to emerging reports linking it to cognitive dysfunction.
February 2026 in “Indian Journal of Dermatology” This study from a dermatology department found that patch test positivity for allergic contact dermatitis is lower in geriatric patients than in adults, likely due to age-related immune changes and reduced allergen exposure.
November 2025 in “Frontiers in Psychiatry” This study found that individuals with androgenetic alopecia experience significantly higher symptoms of anxiety, depression, and stress compared to controls, along with reduced self-esteem and life satisfaction, highlighting the importance of addressing psychological well-being in clinical treatments.
November 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” This study found that patients with androgenetic alopecia experience significantly higher symptoms of anxiety, depression, stress, and body image dissatisfaction compared to non-AGA controls, along with generally reduced self-esteem and life satisfaction.